Canwen Jiang Selected Research

Canwen Jiang Research Topics

Disease

9	Hypoxia (Hypoxemia) 09/2010 - 02/2002
6	Infections 02/2005 - 02/2002
3	Hyperplasia 04/2005 - 03/2004
2	Insulin Resistance 06/2010 - 07/2009
2	Glycogen Storage Disease Type II (Pompe's Disease) 06/2009 - 08/2005
2	Ischemia 05/2009 - 02/2005
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 05/2009 - 06/2006
2	Pathologic Constriction (Stenosis) 04/2005 - 10/2004
2	Reperfusion Injury 02/2005 - 07/2003
2	Heart Failure 07/2003 - 07/2003
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2013
1	Respiratory Hypersensitivity 07/2010
1	Asthma (Bronchial Asthma) 07/2010
1	Pneumonia (Pneumonitis) 07/2010
1	Gaucher Disease (Gaucher's Disease) 06/2010
1	Obesity 06/2010
1	Body Weight (Weight, Body) 07/2009
1	Thrombosis (Thrombus) 04/2005
1	Neointima 10/2004
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2004
1	Neoplasms (Cancer) 10/2004
1	Carcinoma (Carcinomatosis) 10/2004
1	Starvation 10/2003
1	Cardiomyopathies (Cardiomyopathy) 07/2003
1	Cardiotoxicity 07/2003
1	Hypertension (High Blood Pressure) 07/2002
1	Cardiomegaly (Heart Hypertrophy) 07/2002
1	Atherosclerosis 07/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2002
1	Glioma (Gliomas) 03/2002

Drug/Important Bio-Agent (IBA)

7	Etoposide (VP 16)FDA LinkGeneric 05/2009 - 02/2002
6	Proteins (Proteins, Gene)FDA Link 01/2013 - 02/2002
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2009 - 03/2002
5	Messenger RNA (mRNA)IBA 02/2005 - 03/2002
4	EnzymesIBA 07/2010 - 08/2005
4	Glucose (Dextrose)FDA LinkGeneric 06/2010 - 07/2002
3	Deferoxamine (Desferal)FDA LinkGeneric 09/2010 - 07/2002
2	GlycosphingolipidsIBA 07/2010 - 07/2009
2	LipidsIBA 07/2010 - 12/2007
2	alpha-Glucosidases (Acid Maltase)IBA 06/2009 - 08/2005
2	AcidsIBA 06/2009 - 08/2005
2	PPAR alphaIBA 12/2007 - 07/2002
2	Hypoxia-Inducible Factor 1IBA 12/2007 - 03/2002
2	beta-adrenergic receptor kinase inhibitory peptideIBA 04/2005 - 10/2004
2	beta-Adrenergic Receptor KinasesIBA 04/2005 - 10/2004
2	Phenobarbital (Luminal)FDA Link 04/2005 - 10/2004
2	angiopoietin 4IBA 10/2004 - 10/2003
2	AngiopoietinsIBA 10/2004 - 07/2002
2	Fas Ligand Protein (Fas Ligand)IBA 03/2004 - 07/2003
2	CaspasesIBA 07/2003 - 08/2002
1	dimethyloxallyl glycineIBA 09/2010
1	UDPgalactose-glucosylceramide galactosyltransferaseIBA 07/2010
1	OvalbuminIBA 07/2010
1	Antisense OligonucleotidesIBA 07/2010
1	Insulin (Novolin)FDA Link 06/2010
1	eliglustatIBA 06/2010
1	Hemoglobins (Hemoglobin)IBA 07/2009
1	Triglycerides (Triacylglycerol)IBA 07/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2007
1	Retinoid X Receptors (Retinoid X Receptor)IBA 12/2007
1	DNA (Deoxyribonucleic Acid)IBA 12/2007
1	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2006
1	Phosphates (Orthophosphate)IBA 08/2005
1	Mannose (D-Mannose)IBA 08/2005
1	CarbohydratesIBA 08/2005
1	human GAA protein (Myozyme)FDA Link 08/2005
1	LigandsIBA 08/2005
1	CationsIBA 08/2005
1	Polytetrafluoroethylene (Teflon)FDA Link 04/2005
1	NF-kappa B (NF-kB)IBA 02/2005
1	Herpes Simplex Virus Protein Vmw65IBA 02/2005
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2005
1	Cytostatic AgentsIBA 03/2004
1	Angiopoietin-2IBA 10/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2003
1	Antineoplastic Agents (Antineoplastics)IBA 07/2003
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2002
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2002
1	Sodium CyanideIBA 07/2002
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 07/2002
1	PPAR gammaIBA 07/2002
1	cobaltous chloride (cobalt(II)chloride)IBA 07/2002

Therapy/Procedure

3	Therapeutics 05/2009 - 07/2003
1	Intranasal Administration 07/2010
1	Enzyme Replacement Therapy 08/2005
1	Renal Dialysis (Hemodialysis) 04/2005
1	Catheters 10/2004
1	Stents 03/2004